SRP4872
GDF9 human
recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Manufacturer: Sigma Aldrich
Synonym(S): GDF9, Growth/differentiation factor 9
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 20 μG | SRP4872-20-μG | In Stock | ₹ 35,257.03 |
SRP4872 - 20 μG
In Stock
Quantity
1
Base Price: ₹ 35,257.03
GST (18%): ₹ 6,346.265
Total Price: ₹ 41,603.295
biological source
human
recombinant
expressed in E. coli
Assay
≥98% (HPLC)≥98% (SDS-PAGE)
form
lyophilized
mol wt
~31.2 kDa
packaging
pkg of 20 μg
impurities
endotoxin, tested
NCBI accession no.
O60383
UniProt accession no.
O60383
shipped in
wet ice
Related Products
Description
- General description: GDF-9 is a member of the TGF-β superfamily of growth and differentiation factors, and is highly homologous to GDF-3. Unlike most TGF-family members, GDF-9 and GDF-3 are not disulfide-linked dimers. GDF-3 is expressed in adult bone marrow, spleen, thymus, and adipose tissue. GDF-9 is expressed in oocytes and is required for normal ovarian folliculogenesis. Recombinant human GDF-9 is a 31.0 kDa non-disulfide-linked homodimer containing two 135 amino acid polypeptide chains with 6XHis on its N-terminus.
- Application: GDF9 has been as a supplement in the basal medium for the maturation of cumulus–oocyte complexes (COCs).[1]
- Biochem/physiol Actions: Growth differentiation factor 9 (GDF9) is known to be localized in the cytoplasm. The gene encoding it is localized on human chromosome 5q31.1. It is known to be associated with granulosa cell proliferation and steroid production. Downregulation of the gene is observed in polycystic ovary syndrome.[2][3][4]
- Physical form: Sterile filtered and lyophilized with no additives.
- Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~31.2 kDa
packaging: pkg of 20 μg
impurities: endotoxin, tested
NCBI accession no.: O60383
UniProt accession no.: O60383
shipped in: wet ice
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~31.2 kDa
packaging:
pkg of 20 μg
impurities:
endotoxin, tested
NCBI accession no.:
O60383
UniProt accession no.:
O60383
shipped in:
wet ice
biological source: mouse
recombinant: expressed in E. coli
Assay: ≥90% (SDS-PAGE)
form: lyophilized
mol wt: ~30 kDa
packaging: pkg of 25 μg
impurities: endotoxin, tested
NCBI accession no.: Q60994
UniProt accession no.: __
shipped in: wet ice
biological source:
mouse
recombinant:
expressed in E. coli
Assay:
≥90% (SDS-PAGE)
form:
lyophilized
mol wt:
~30 kDa
packaging:
pkg of 25 μg
impurities:
endotoxin, tested
NCBI accession no.:
Q60994
UniProt accession no.:
__
shipped in:
wet ice
biological source: human
recombinant: expressed in Saccharomyces cerevisiae
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~19.5 kDa
packaging: pkg of 10 μg
impurities: endotoxin, tested
NCBI accession no.: Q13007
UniProt accession no.: __
shipped in: wet ice
biological source:
human
recombinant:
expressed in Saccharomyces cerevisiae
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~19.5 kDa
packaging:
pkg of 10 μg
impurities:
endotoxin, tested
NCBI accession no.:
Q13007
UniProt accession no.:
__
shipped in:
wet ice
biological source: human
recombinant: expressed in E. coli
Assay: ≥95% (HPLC)≥95% (SDS-PAGE)
form: lyophilized
mol wt: ~52 kDa
packaging: pkg of 10 μg
impurities: __
NCBI accession no.: P23560
UniProt accession no.: __
shipped in: wet ice
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥95% (HPLC)≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
~52 kDa
packaging:
pkg of 10 μg
impurities:
__
NCBI accession no.:
P23560
UniProt accession no.:
__
shipped in:
wet ice